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Abstract 
  BACKGROUND: Direct surgery or endovascular procedures are an accepted way of treating pa 
tients with Aneurismal Subarachnoid Haemorrhage (SAH). However the impact of invasive me 
thods of treatment on results in developing countries may differ from that in developed coun 
tries. 
  METHODS:  This  is  a  prospective  clinical  study  of  consecutive  patients  with  Subarachnoid 
Haemorrhage (SAH) admitted in Ghaem hospital in Mashhad during 2005 2010. The initial di 
agnosis and investigations were carried out by neurologists. The patients were divided into two 
groups. One received surgical treatment whilst the other group was managed medically. The de 
cision as to the choice of method of treatment was made by the neurosurgeons. The initial medi 
cal treatment was standardised for all the patients. The rate of complications and mortality was 
compared in both medical and surgical groups. 
  RESULTS: 120 SAH patients (52% females) with a mean age of 50.6 ± 7 years were evaluated. 
The angiography revealed the presence of an aneurysm in 62 patients. 63.5% of patients re 
ceived medical treatment and 37.5% underwent aneurysmal surgery. Difference of rebleeding 
rate in two therapeutic groups was not significant; χ2 = 0.014, P = 0.91. The effect of rebleeding 
on mortality was not significant; χ2 = 2.54, P = 0.14. Within 62 SAH patients with cerebral aneu 
rysm, the mortality rate in both therapeutic groups was also not significantly different; χ2 = 0.16, 
P = 0.77. 
  CONCLUSION: There is no significant difference in the mortality rate between the “surgical” 
and non “surgical” groups of patients with SAH. This could be due to delay in performance of 
surgery in neurovascular centers in Iran. 
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Introduction 
The outcome for patients with SAH remains poor, 
with mortality rates up to 45%, and there is significant 
morbidity among survivors.1 The review of literature 
and prospective cohorts has shown that for untreated, 
ruptured aneurysms, there is at least a 3 4% risk of 
rebleeding in the first 24 hours and 1 2% per day in 
the first month.2 Urgent investigation and treatment 
of patients with suspected SAH is therefore recom 
mended.2  The  major  complications  following  SAH 
are due to ischaemic deficit (27%) and hydrocephalus 
(12%).3  However  the  most  feared  complication  for 
survivors  of  the  initial  haemorrhage  is  recurrent 
bleeding, which occurs in 15 20% of the patients and 
is associated with a 40 78% mortality.3 The definitive 
method for prevention of rebleeding is to secure the 
aneurysm as soon as possible.2 Early surgery may not 
be appropriate for every patient with SAH but every 
attempt should be made to secure the aneurysm as 
soon as possible to prevent rebleeding.3 Unfortunate 
ly in our country many patients with SAH are admit 
ted to hospitals without facilities for catheter angio 
graphy, aneurysmal coiling, or direct aneurysmal sur 
gery. Even in tertiary care hospitals with these facili 
ties, many of the SAH patients are admitted after 3 
days following the ictus and for this reason the sur 
gical or endovascular treatment is delayed for up to 3 
weeks post the event. Unfortunately there is no policy 
of urgency in the Emergency Departments to direct 
the patients with SAH for appropriate management. 
Additionally, some of our SAH patients refuse sur 
gery on cultural or economic grounds. In this paper 
we report the first prospective study of aneurysmal 
surgery in patients with SAH in Iran. 
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Materials and Methods 
Consecutive patients with Subarachnoid Hemorrhage 
(SAH) admitted in Ghaem hospital, Mashhad, during 
2005 2010  were  enrolled  in  a  prospective  clinical 
study. Our hospital is a University tertiary care center 
in  north east  of  Iran.  Neurologists,  neurosurgeons, 
and radiologists are available 24 hours per day and 7 
days per week in the hospital. SAH patients who died 
before arriving to hospital were excluded from this 
study. The initial Hunt and Hess scale of each SAH 
patient on arrival to the hospital was recorded in both 
therapeutic groups. Diagnosis of SAH was based on a 
brain CT scan. Patients suspected to have a SAH but 
with normal brain CT scan underwent a FLAIR MRI 
scan and lumbar puncture.4,5 Catheter cerebral angio 
graphy  is  a  routine  diagnostic  investigation  in  our 
SAH  patients  and  is  performed  by  general  radiolo 
gists. SAH patients with an initially normal cerebral 
angiography usually underwent a second angiography 
after 3 weeks. Patients who did not have cerebral an 
giography  due  to  poor  medical  condition  or  early 
death in hospital or allergy to contrast material were 
excluded. Positive angiogram for aneurysm was found 
in  63.5%  of  our  SAH  patients.  SAH  patients  were 
usually admitted for 3 weeks in either Neurology or 
Neurosurgery divisions. In our center, cerebral angio 
graphy followed by aneurysmal clipping is usually per 
formed  on  patients  with  SAH  within  the  first  72 
hours post SAH. Patients who arrive to hospital after 
this  time  or  were  initially  comatose  were  usually 
treated medically and diagnostic procedures and sur 
gery if required were performed in this group of cases 
after 3 weeks post the event. SAH patients who un 
derwent  craniotomy  and  aneurysmal  clipping  were 
categorized as a surgical therapeutic group. Aneurys 
mal clipping is the usual type of surgical procedure in 
our hospital for these patients. Aneurysmal wrapping 
is  not  performed  and  endovascular  coiling  is  not 
available. Patients who underwent ventricular shunt 
ing  for  hydrocephalus  without  aneurysmal  clipping 
were included in the medical therapeutic group. Sur 
gical decision of the patient for aneurysm was made 
by a neurosurgeon. General medical condition of the 
patients was assessed by anesthetists and patients with 
poor cardiopulmonary or medical condition were ex 
cluded. SAH patients with Hunt and Hess scale of 5 
were  also  excluded.  Despite  neurosurgical  recom 
mendation, some of our patients refused surgery due 
to cultural aspects or lack of funds. The medical man 
agement  received  was  standardized  in  both  surgical 
and  medical  groups  of  SAH  patients.  Principles  of 
medical management included; analgesia, Nimodipine, 
sedatives, laxatives, control of blood pressure and 3 
litres of Normal Saline per day.4,5 Demographic fea 
tures, risk factors, cerebral CT findings, clinical ma 
nifestations  and  aneurysm  characteristics  were  eva 
luated in all patients. Mortality and complications in 
SAH, including rebleeding, hydrocephalus and brain 
infarction due to vasospasm, were recorded in both 
medical and surgical groups of patients during hospi 
talization. The time was recorded and compared in 
each therapeutic group from SAH onset to hospital 
arrival, SAH onset to death, SAH onset to surgery 
(where applicable) and surgery (where applicable) to 
death in all patients. Chi Square and Fisher tests were 
used for statistical analysis and P < 0.05 declared as 
significant. The research project was approved by the 
ethics  committee  of  our  hospital  and  an  informed 
signed consent was taken from patients or their first 
degree relatives. 
Results 
The  results  of  the  treatment  of  one  hundred  and 
twenty SAH patients (63 females, 57 males) with a 
mean age 50.6 ± 7 years were prospectively evaluated. 
SAH was detected on cerebral CT in 95% of the cas 
es.  The  patients  were  divided  into  two  therapeutic 
groups. Among our SAH patients, 62.5% with mean 
age of 52.4 ± 5 received medical treatment and 37.5% 
with mean age of 49.7 ± 3 were subjected to surgery.  
  Hypertension, smoking, oral  contraceptive medi 
cation, past trauma and over dosage of oral anticoagu 
lation therapy were found in 41.6%, 19.1%, 0%, 0%, 
and 0.8% of patients respectively. Fifty six patients 
were  subjected  to  surgery,  of  whom  45  underwent 
craniotomy and aneurysmal clipping, while 11 cases 
had  CSF shunting  without  aneurysmal  clipping  and 
were  included  into  the  medically  managed  group. 
Overall  mortality  was  44.2%  of  all  SAH  patients 
(60.4% of females and 39.6% of males). There was no 
statistically significant difference in the death rate be 
tween the two therapeutic groups (χ2 = 1.54, df = 1,  
P = 0.11) and no significant difference between the 
females and males (χ2 = 0.73, df = 1, P = 0.39).  
  The mean SAH onset to admission time in whole 
of our SAH patients and in their medical and surgical 
groups were 66 ± 4, 84 ± 1 and 24 ± 7 hours respec 
tively.  The  overall  mean  timing  from  the  onset  of 
SAH  to  death  was  14.1  ±  2  days.  In  the  surgical 
group, the mean length of time from onset of SAH to 
surgery was 8.4 ± 3 days and of those who died, the 
mean length of the time between surgery and death 
was 5.9 ± 3 days.  
  Table 1 compares the characteristics between sur 
gical and medical groups. The effect of therapeutic 
type of aneurysm management on mortality was not 
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significant (χ2 = 0.16, P = 0.77). Rebleeding occurred 
in 4.4% of patients in the surgical group and 4% in 
the medical group and the difference was not statisti 
cally significant (χ2 = 0.014, P = 0.91). Among 5 SAH 
patients with rebleeding, 2 had an anterior communi 
cating artery aneurysm and 3 had a “normal angiogra 
phy”. The influence of rebleeding on the overall mor 
tality  was  not  statistically  significant  (χ2  =  2.54,  
P = 0.14). None of the studied patients had rebleed 
ing before admission to hospital. However rebleeding 
may have occurred in patients who died before arriv 
ing to the hospital and these were not included in this 
study. Hydrocephalus was found in 17 patients and its 
frequency was not significantly different in the two 
therapeutic groups (χ2 = 5.58, P = 0.03).  
  Out of 17 SAH patients with hydrocephalus, 13 
(76%) died and the effect of hydrocephalus on the 
mortality of these patients was significant (χ2 = 7.93,  
P = 0.007). Cerebral infarction due to vasospasm oc 
curred in 7 (5.8%) patients (4.4% of the surgical and 
6.7% of the medical group).  
  The choice of aneurysmal therapeutic strategy on 
frequency  of  cerebral  infarction  was  not  significant  
(χ2 = 0.25, P = 0.71). Out of seven patients with brain 
infarction  due  to  vasospasm,  three  cases  died.  The 
effect of cerebral infarction on the overall mortality of 
SAH patients was not significant (χ2 = 0.005, P = 1).  
  Table 2 represents distribution of complications in 
two  therapeutic  groups  of  our  patients.  Aneurysms 
were found in the angiography of 62 patients (45 in 
the  surgical  and  17  in  the  medical  group).  The 
distribution was as follows: Anterior communicating 
artery 41.9%, middle cerebral artery 23.1%, internal 
carotid artery 14.5%, basilar artery 4.8%, anterior ce 
rebral  artery  4.8%,  posterior  communicating  artery 
6.4%, and multiple aneurysms 3%. Among 62 SAH 
patients with aneurysm on angiography, 45 patients 
(72.6%)  underwent  aneurysm  surgery  and  17  cases 
(27.4%)  received  only  medical  management.  Death 
was recorded in 48.9% of SAH patients with aneu 
rysm who underwent aneurysm surgery (22/45) and 
41.2% of patients with aneurysm who only received 
medical management (7/17).  
  High Hunt and Hess scale, poor general medical 
condition and refusal of patients constituted reason of 
excluding these 17 cases with aneurysm from surgical 
group in 58.8%, 29.4% and 11.7% respectively. De 
tails of Hunt and Hess scales of these seventeen cases 
are presented in Table 1. The difference in the mor 
tality rate in 62 SAH patients with angiographically 
confirmed aneurysms in two therapeutic groups was 
not statistically significant (χ2 = 0.16, P = 0.77).  
Discussion 
In aneurysmal surgery, delay in treatment is associated 
with  increased  rates  of  pre operative  rebleeding,  in 
both retrospective and prospective studies.2 Recently 
it has been associated with higher rates of poor out 
come.2,6 The International Co operative Study on the 
Timing of Aneurysmal Surgery, analysed management 
of 3521 patients, of whom 83% underwent surgical 
repair  of  the  ruptured  aneurysm.7  The  timing  of 
 
Table 1. Clinical characteristics of surgical and medical groups of our SAH patients 
Death  H-H-S 5  H-H-S 4  H-H-S 3  H-H-S 2  H-H-S 1  Therapeutic 
group/H-H-S* 
28 (62.2%) 
 
-  6  24  14  1  Surgical (n:45) 
(F: 25, M: 20) 
18 (31%)  8  11  26  12  1  Medical  without 
aneurysm (n: 58) 
(F: 29, M:29) 
7 (41.2%)  10  7  -  -  -  Medical with aneu-
rysm (n:17) 
(F:9, M:8) 
53 (44.2%)  18  24  50  26  2  Total (n:120) 
(F:63, M:57) 
H-H-S: Hunt Hess Scale 
*: None of our SAH patients had Hunt Hess scale 0. 
 
Table 2. Distribution of complications and outcome in two therapeutic groups of our SAH patients 
Death  Infarction 
due to va-
sospasm 
Ventricular 
shunting 
Hydrocephaly  Death due 
to rebleed-
ing 
Rebleeding  Therapeutic 
group/ 
28 (62.2%)  2 (4.4%)  2 (4.4%)  2 (4.4%)  -  2 (4.4%)*  Surgical (n:45) 
25 (33.3%)  5 (6.7%)  11 (14.7%)  15 (20%)  2 (2.7%)  3 (4%)  Medical (n:75) 
53 (44.2%)  7 (5.8%)  13 (10.8%)  17 (14.2%)  2 (1.7%)  5 (4.2%)  Total (n:120) 
* Rebleeding occurred before aneurysm clipping 
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surgery after SAH was significantly related to the like 
lihood of pre operative rebleeding. Patients who un 
derwent early surgery had a significantly lower pre 
operative rebleed rate than those who underwent later 
surgery (3% versus 11%).7 The mean time of onset to 
surgery in our SAH patients was 8 days which is long 
er than reported in western countries.6 This signifi 
cant delay in the timing of aneurysmal surgery in our 
patients, could be the main reason for failure to de 
crease mortality in our patients. During this period of 
delay  a  number  of  complications may  occur  in  the 
surgical group. In recent years, there has been a trend 
towards early surgery for ruptured aneurysms, espe 
cially in good and moderate grade patients.2,6 In addi 
tion, early surgery facilitates the possibility of aggres 
sive  therapy of  vasospasm.2  However,  it  is  also  re 
ported that there were no overall differences in out 
come  in  patients  operated  on  early  (0 3  days  post 
SAH) or late (11 14 days post SAH).6 Surgical mortal 
ity was higher with early surgery due to brain swelling, 
disturbed  autoregulation  and  haemorrhage.6  The 
treatment was most hazardous between days 7 and 10 
due to the combined risks of rebleeding and vasos 
pasm.6 A prospective study, from three centers, indi 
cates that despite attempts to do early surgery, reb 
leeding is still a significant problem, because only one 
half of the patients were operated on within 72 hours, 
and 35% of the patients with poor outcome had suf 
fered  rebleeding.8,9  In  addition,  some  SAH  patients 
with  acute  hydrocephalus  may  benefit  from  early 
placement  of  a  ventricular  drain  in  the  hospital.10 
Acute  hydrocephalus  is  more  frequent  in  patients 
with poor clinical grade. The clinical significance of 
acute hydrocephalus after SAH is uncertain because 
many  patients  are  apparently  asymptomatic  and  do 
not deteriorate.2 There was no statistical significance 
between the type of management, mortality and com 
plications in our patients. The impact of rebleeding 
despite presence of hydrocephalus on mortality was 
not  significant  in  our  patients.  This  is  inconsistent 
with results in developed countries.11 The late presen 
tation of the SAH patients in our center, compared to 
developed countries is a local issue and this leads to 
late treatment. The logistic multivariate regression test 
is necessary, to access the exact influence of the the 
rapeutic subtype of aneurysm, on in hospital death in 
SAH patients. However, this type of analysis needs 
more than five hundred SAH cases, which is out of 
our reach in the near future. Meanwhile, we consider 
our work the first pilot study conducted in this field 
in Iran.  
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